LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 80.48 | 771.67 | 9276 | 11685 | 0.7938 | 0.8856 | MN20160304_L01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 82.69 | 771.67 | 9962 | 11974 | 0.8320 | 0.9091 | MN20160304_L01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 82.69 | 771.67 | 9558 | 11974 | 0.7982 | 0.8893 | MN20160304_L01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 84.92 | 771.67 | 10246 | 12266 | 0.8353 | 0.9118 | MN20160304_L01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 84.92 | 771.67 | 9992 | 12266 | 0.8146 | 0.8998 | MN20160304_L01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 87.14 | 771.67 | 10744 | 12592 | 0.8532 | 0.9227 | MN20160304_L01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 87.14 | 771.67 | 10273 | 12592 | 0.8158 | 0.9014 | MN20160304_L01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 2.49 | 771.67 | 912 | 867 | 1.0510 | 1.6830 | MN20160304_L01 | D18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 2.49 | 771.67 | 733 | 867 | 0.8447 | -0.2619 | MN20160304_L01 | F14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 2.49 | 771.67 | 862 | 867 | 0.9934 | 0.9230 | MN20160304_L01 | N05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 4.71 | 771.67 | 992 | 956 | 1.0373 | 1.2508 | MN20160304_L01 | D18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 4.71 | 771.67 | 819 | 956 | 0.8564 | 0.2120 | MN20160304_L01 | F14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 4.71 | 771.67 | 935 | 956 | 0.9777 | 0.8592 | MN20160304_L01 | N05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 6.94 | 771.67 | 1032 | 1045 | 0.9874 | 0.9431 | MN20160304_L01 | D18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 6.94 | 771.67 | 886 | 1045 | 0.8478 | 0.3712 | MN20160304_L01 | F14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 6.94 | 771.67 | 1004 | 1045 | 0.9607 | 0.8247 | MN20160304_L01 | N05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 9.16 | 771.67 | 1120 | 1138 | 0.9838 | 0.9425 | MN20160304_L01 | D18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 9.16 | 771.67 | 939 | 1138 | 0.8248 | 0.4188 | MN20160304_L01 | F14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 9.16 | 771.67 | 1086 | 1138 | 0.9539 | 0.8386 | MN20160304_L01 | N05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 11.56 | 771.67 | 1210 | 1280 | 0.9449 | 0.8506 | MN20160304_L01 | D18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 11.56 | 771.67 | 990 | 1280 | 0.7731 | 0.4063 | MN20160304_L01 | F14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 11.56 | 771.67 | 1161 | 1280 | 0.9066 | 0.7489 | MN20160304_L01 | N05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 13.78 | 771.67 | 1328 | 1459 | 0.9097 | 0.8045 | MN20160304_L01 | D18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 13.78 | 771.67 | 1059 | 1459 | 0.7255 | 0.4108 | MN20160304_L01 | F14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 13.78 | 771.67 | 1246 | 1459 | 0.8536 | 0.6837 | MN20160304_L01 | N05 |